Expression of receptors in the pNK cells of both the fertile
control and RM group
The percentage of
NKG2D+ (67.9% ± 12.6% vs 68.4% ± 12.6%,
Fig. 3A and B), NKp30+ (45.3% ± 16.5% vs52.1% ± 21.9%, Fig. 3A and C), NKp46+ (53.6% ±
16.4% vs 55.2% ± 19.6%, Fig. 3A and D),
CD158a+ (42.8% ± 21.2% vs 45.0% ± 18.3%,
Fig. 4A and B), CD158b+ (36.8% ± 18.9% vs40.1% ± 18.4%, Fig. 4A and D) pNK cells were not significantly
different between the fertile control group and RM group. Furthermore,
the MFI of NKG2D (685.1 ± 154.4 vs 641.3 ± 95.0, Fig. 3A and E),
NKp30 (1966.3 ± 374.6 vs 2052.3 ± 499.8, Fig. 3A and F), and
NKp46 (1795.1 ± 258.3 vs 1809.2 ± 663.2, Fig. 3A and G)
expression in the pNK cells between these two groups were also not
significantly different. However, the MFI of CD158a (1509.7 ± 644.0vs 2060.7 ± 525.0, P = 0.004, Fig. 4A and C) and CD158b
(4850.4 ± 333.1 vs 5584.9 ± 1580.1, P = 0.004, Fig. 4A and
E) expression in the pNK cells were higher in RM group than that in the
control group.